State of Wisconsin Investment Board’s ArriVent BioPharma AVBP Stock Holding History

State of Wisconsin Investment Board’s Portfolio AVBP Stock Details AVBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$343K	Buy	+9,883	New	+$292K	﹤0.01%	2243

Other funds holding AVBP

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State of Wisconsin Investment Board's AVBP Position: Q2 2026 in Review

State of Wisconsin Investment Board opened a new position in ArriVent BioPharma (AVBP) in Q2 2026: 9,883 shares worth $343K. The stake represents ﹤0.01% of the portfolio and ranks #2243 among its holdings.

157 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.

State of Wisconsin Investment Board held 9,883 shares of ArriVent BioPharma worth $343K as of Q2 2026.
ArriVent BioPharma was a new State of Wisconsin Investment Board position in Q2 2026.
ArriVent BioPharma made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q2 2026, its #2243 holding.
157 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.